Balance Sheets (USD $)	Oct. 31, 2013	Jul. 31, 2013
Current assets
Cash and cash equivalents	$ 323,709	$ 598,623
Prepaid insurance	12,750	21,250
Total current assets	336,459	619,873
Other assets
Patents and patent applications (net of accumulated amortization of $4,689 at October 31, 2013 and $4,270 at July 31, 2013)	22,761	23,180
Total assets	359,220	643,053
Current liabilities
Accounts payable and accrued liabilities	24,343	40,767
Accrued salaries and wages	532,050	457,636
Due to related party	350,000	350,000
Convertible notes payable	25,000	25,000
Derivative liability	519,400	9,666
Total current liabilities	1,450,793	883,069
Deferred revenue	750,000	750,000
Total liabilities	2,200,793	1,633,069
Stockholders' deficit
Common stock; par value $0.001; 200,000,000 shares authorized; 168,409,106 shares issued and outstanding at October 31, 2013 and 164,699,973 shares issued and outstanding at July 31, 2013	168,409	164,700
Additional paid-in capital	34,554,246	33,695,679
Accumulated deficit during the development stage	(36,564,228)	(34,850,395)
Total stockholders' deficit	(1,841,573)	(990,016)
Total liabilities and stockholders' deficit	$ 359,220	$ 643,053